medline.ch Onkologie Urologische Tumoren

	Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB. PMID: 41543856 [PubMed - indexed for MEDLINE]
	(18)F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatment. Int J Clin Oncol Murata S, Moribata Y, Akamatsu S, Kido A, Himoto Y, Kurata Y, Otani T, Sumiyoshi T, Saito R, Ogata T, Aizawa R, Nakamura K, Mizowaki T, Nakamoto Y, Kobayashi T, Goto T. PMID: 41543807 [PubMed - as supplied by publisher]
	Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives. Clin Exp Med Chen X, Ke Y, Huang X, Chen J, Chen J, Chen Z. PMID: 41543784 [PubMed - as supplied by publisher]
	Predictive factors for negative prostate biopsy in PI-RADS 5 patients: a multivariate analysis of clinical and imaging-based factors. World J Urol Acevedo C, Arroyave JS, López L, Saldivia D, Singhal M, Moya F, Sánchez C, Larenas F. PMID: 41543542 [PubMed - indexed for MEDLINE]
	Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer. Jpn J Clin Oncol Hirose K, Yoshida S, Chen W, Yajima S, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y. PMID: 41543049 [PubMed - as supplied by publisher]
	Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan. Jpn J Clin Oncol Kawai T, Miki J, Taoka R, Saito R, Fukuokaya W, Matsui Y, Fujii Y, Hatakeyama S, Kawahara T, Matsuda A, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Nakayama M, Matsumoto T, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Kobayashi K, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kume H, Japan Urological Oncology Group. PMID: 41543041 [PubMed - as supplied by publisher]
	Pitfalls and Limitations of the Vesical Imaging-Reporting and Data System (VI-RADS): Challenges in the Multiparametric Magnetic Resonance Imaging (mpMRI) Assessment of Bladder Cancer. Cureus Laert J, Lupi Manso N, França de Santana T, Santos PO. PMID: 41541939 [PubMed]
	Best evidence summary on gastrointestinal function recovery after radical cystectomy for bladder cancer. Asia Pac J Oncol Nurs Dai Y, Zhang X, Lin Q, Gu X. PMID: 41541189 [PubMed]
	Survival for Children Diagnosed With Wilms Tumour (2012-2022) Registered in the UK and Ireland Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) Study. Pediatr Blood Cancer Ssenyonga N, Lopez-Cortes A, Al-Saadi R, Tugnait S, Dzhuma K, Duncan C, Vujanic G, Chowdhury T, Allemani C, Coleman MP, Pritchard-Jones K, Children's Cancer and Leukaemia Group (CCLG) Renal Tumour Special Interest Group. PMID: 41540889 [PubMed - as supplied by publisher]
	Clinical, Cytologic, Histopathologic, and Diagnostic Imaging of a Malignant Peripheral Nerve Sheath Tumor in the Renal Pelvis of a Border Collie Dog. Vet Clin Pathol Romero-Vélez F, Serrano B, Martínez-Caro J, González-Rellán S, Novellas R, García-Ferrer A, Pastor J, Solano-Gallego L. PMID: 41540823 [PubMed - as supplied by publisher]
	Tissue polypeptide antigen as a non-invasive bladder Cancer biomarker. Clin Chim Acta Fuloria NK, Narain K, Biswas A, Gnanam P, Dhandapani SV, Biswas S, Bhatia S, Fuloria S. PMID: 41539640 [PubMed - as supplied by publisher]
	Comment to: ALBAN (GETUG-AFU 37): A phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-GuÃ©rin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladder cancer (NMIBC). Ann Oncol Contieri R, Mollica V, Shariat SF, Pradere B. PMID: 41539604 [PubMed - as supplied by publisher]
	Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer-Reply. JAMA Ng ABCD, Asif A, Kasivisvanathan V. PMID: 41538205 [PubMed - as supplied by publisher]
	Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer. JAMA Lombardo R, Lorenti C, De Nunzio C. PMID: 41538176 [PubMed - as supplied by publisher]
	Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. JAMA Perera Molligoda Arachchige AS. PMID: 41538169 [PubMed - as supplied by publisher]
	Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. JAMA Lin HC, Chen HT, Chang CM. PMID: 41538161 [PubMed - as supplied by publisher]
	Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic Implications. Cancer Med Lin DI, Lawrence E, Danziger N, Ye H, Decker B, Gjoerup O, Graf RP, Ross JS, Huang RSP, Elvin JA, Mata DA, McKay RR. PMID: 41538264 [PubMed - indexed for MEDLINE]
	Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study. BJU Int Zaurito P, Garmo H, Gedeborg R, Alhberg M, Carlsson S, Thellenberg C, Robinson D, Stattin P, Westerberg M. PMID: 41537396 [PubMed - as supplied by publisher]
	Development and Validation of a Machine Learning-Based Radiomics Model Using Ultrasound Image Features for Prostate Cancer Risk Stratification. Ann Ital Chir Zhao A, Du S, Du Y, Zhang M, Wu J, Wang Z, Hu L. PMID: 41537209 [PubMed - indexed for MEDLINE]
	Current and future perspectives on radioligand therapy in advanced prostate cancer. Ther Adv Med Oncol Ahmed B, Ravi P. PMID: 41536963 [PubMed]

Artikel 1 - 20 / 175247

Seite 1 von 8763

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung